Sara Pisani

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS survey.

Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS survey.

Journal: Obesity pillars

Published: May 06, 2026

Using retinal diagnostics as a biomarker for neurodegenerative diseases: protocol for a systematic review.

Using retinal diagnostics as a biomarker for neurodegenerative diseases: protocol for a systematic review.

Journal: BMJ open

Published: November 17, 2025

Gray Matter Volume Loss in Parkinson's Disease Psychosis and Cannabinoid Receptor Gene Expression in the Brain.

Gray Matter Volume Loss in Parkinson's Disease Psychosis and Cannabinoid Receptor Gene Expression in the Brain.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: February 19, 2025

Aprosopsia: a novel metamorphopsia variant occurring in Parkinson's disease psychosis.

Aprosopsia: a novel metamorphopsia variant occurring in Parkinson's disease psychosis.

Journal: Journal of neurology

Published: February 17, 2025

Decline in striatal binding ratio associated with accelerated decline in performance on symbol digit modality but not MoCA in Parkinson's Disease Psychosis.

Decline in striatal binding ratio associated with accelerated decline in performance on symbol digit modality but not MoCA in Parkinson's Disease Psychosis.

Journal: BMJ mental health

Published: October 24, 2024

Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.

Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference.

Journal: Age and ageing

Published: April 29, 2024

Parkinson's disease psychosis associated with accelerated multidomain cognitive decline.

Parkinson's disease psychosis associated with accelerated multidomain cognitive decline.

Journal: BMJ mental health

Published: March 05, 2024

Cannabidiol for behavior symptoms in Alzheimer's disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial.

Cannabidiol for behavior symptoms in Alzheimer's disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial.

Journal: International psychogeriatrics

Published: February 22, 2024

Functional and connectivity correlates associated with Parkinson's disease psychosis: a systematic review.

Functional and connectivity correlates associated with Parkinson's disease psychosis: a systematic review.

Journal: Brain communications

Published: September 10, 2023

Cognitive and executive impairments in Parkinson's disease psychosis: a Bayesian meta-analysis.

Cognitive and executive impairments in Parkinson's disease psychosis: a Bayesian meta-analysis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 29, 2022

Grey matter volume loss in Parkinson's disease psychosis and its relationship with serotonergic gene expression: A meta-analysis.

Grey matter volume loss in Parkinson's disease psychosis and its relationship with serotonergic gene expression: A meta-analysis.

Journal: Neuroscience and biobehavioral reviews

Published: November 22, 2022

Virtual reality-based assessment and treatment of social functioning impairments in psychosis: a systematic review.

Virtual reality-based assessment and treatment of social functioning impairments in psychosis: a systematic review.

Journal: International review of psychiatry (Abingdon, England)

Published: June 14, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026